Yahoo! Finance: ACAD News

ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Finan (EDGAR Online)

Thu, 17 Dec 2009 22:03:03 Etc/GMT

ACADIA PHARMACEUTICALS INC Financials (EDGAR Online Financials)

Sat, 14 Nov 2009 14:04:15 Etc/GMT

RHI Entertainment, Opnext: Midday Volume Plays (at TheStreet.com)

Tue, 10 Nov 2009 17:36:28 Etc/GMT

ACADIA Pharmaceuticals, Inc. Q3 2009 Earnings Conference Call (at Seeking Alpha)

Tue, 10 Nov 2009 01:29:08 Etc/GMT

Acadia 3Q loss narrows on revenue boost (AP)

Mon, 9 Nov 2009 23:26:55 Etc/GMT

Acadia Pharmaceuticals Inc. said Monday its third-quarter loss narrowed on lower costs and a boost in revenue from its drug development partners.

ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (EDGAR Online)

Mon, 9 Nov 2009 21:11:12 Etc/GMT

ACADIA Pharmaceuticals Reports Third Quarter 2009 Financial Results (Business Wire)

Mon, 9 Nov 2009 21:01:00 Etc/GMT

Morningstar Strategist Says Healthcare Bill Will Be Law By End Of Year: Is Your Portfolio Ready? (Wall Street Transcript)

Mon, 9 Nov 2009 18:45:00 Etc/GMT

Q3 2009 ACADIA PHARMACEUTICALS INC Earnings Release - After Market Close (CCBN)

Mon, 9 Nov 2009 12:07:29 Etc/GMT

ACADIA Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 9, 2009 (Business Wire)

Mon, 2 Nov 2009 14:00:00 Etc/GMT

SAN DIEGO----ACADIA Pharmaceuticals Inc. , a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2009 on Monday, November 9, 2009, after the U.S. financial markets close.

ACADIA Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26, 2009 (Business Wire)

Tue, 20 Oct 2009 13:00:00 Etc/GMT

SAN DIEGO----ACADIA Pharmaceuticals Inc. , a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the BIOCOM Investor Conference 2009 on Monday, October 26, 2009 at 2:30 p.m.

"Best In Class" Formulation Of Fentanyl Seen As Breakthrough Treatment By Ladenburg Thalmann Analyst (Wall Street Transcript)

Tue, 20 Oct 2009 12:12:00 Etc/GMT

67 WALL STREET, New York - October 20, 2009 - The Wall Street Transcript has just published its Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors (EDGAR Online)

Thu, 15 Oct 2009 21:21:44 Etc/GMT

ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)

Tue, 6 Oct 2009 16:32:06 Etc/GMT

Biotech Stocks: Mannkind tanks, Acadia rallies (at MarketWatch)

Tue, 6 Oct 2009 16:17:00 Etc/GMT

Drug stocks advance while shares of Mannkind Corp. tank after it reveals in a regulatory filing that it does not foresee entering into a marketing partnership for its inhaled insulin product before the end of the year.

Mannkind Falls on Talk of Partner, FDA Delay: BioBuzz (at TheStreet.com)

Tue, 6 Oct 2009 14:18:12 Etc/GMT

Biovail, Acadia to continue pimavanserin program (AP)

Tue, 6 Oct 2009 11:43:48 Etc/GMT

Canadian biotechnology company Biovail Corp. and Acadia Pharmaceuticals Inc. said Tuesday they will continue to develop pimavanserin as a potential Parkinson's disease treatment, despite failures in one late-stage study.

No Lupus Confab Invite for Immunomedics: BioBuzz (at TheStreet.com)

Tue, 6 Oct 2009 11:42:17 Etc/GMT

ACADIA Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference on October 6, 2009 (Business Wire)

Tue, 6 Oct 2009 11:05:00 Etc/GMT

SAN DIEGO----ACADIA Pharmaceuticals Inc. , a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the JMP Securities Healthcare Focus Conference on Tuesday, October 6, 2009 at 3:00 p.m.

ACADIA Pharmaceuticals Provides Update on Pimavanserin Collaborative Development Program (Business Wire)

Tue, 6 Oct 2009 11:00:00 Etc/GMT

SAN DIEGO----ACADIA Pharmaceuticals Inc. , a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today provided an update on its Phase III program with pimavanserin for Parkinson’s disease psychosis , which is being pursued in collaboration with Biovail Laboratories International SRL , a subsidiary of Biovail Corporation.